NASDAQ:NRSN

Neurosense Therapeutics Stock Insider Trading

etoro logo Buy NRSN
*Your capital is at risk
$0.780
-0.0196 (-2.45%)
At Close: Jun 03, 2026

NeuroSense Therapeutics Stock Insider Power

Based on the 46 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 1.45M and sold 0 NRSN shares in the last 46 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 46 transactions)
100.00
Buy 1.45M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 26, 2026
Buy
Ordinary Shares
A-Award
Eisenberg Or
Chief Financial Officer
C-Suite Officer 200 000
Value: $154.0K
Mar 26, 2026
Buy
Ordinary Shares
A-Award
Binder Hagit
General Manager
Officer 200 000
Value: $154.0K
Mar 26, 2026
Buy
Ordinary Shares
A-Award
Russek-blum Niva
Chief Technology Officer
Officer 200 000
Value: $154.0K
Mar 18, 2026
Buy
Ordinary Shares
Eisenberg Or
Chief Financial Officer
C-Suite Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Eisenberg Or
Chief Financial Officer
C-Suite Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Eisenberg Or
Chief Financial Officer
C-Suite Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Mandil-levin Revital
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Mandil-levin Revital
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Mandil-levin Revital
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Ben-noon Alon
Chief Executive Officer
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Ben-noon Alon
Chief Executive Officer
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Ben-noon Alon
Chief Executive Officer
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Restricted Share Units
Russek-blum Niva
Chief Technology Officer
Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Russek-blum Niva
Chief Technology Officer
Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Russek-blum Niva
Chief Technology Officer
Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Russek-blum Niva
Chief Technology Officer
Officer 0
Value: $0
Mar 18, 2026
Buy
Restricted Share Units
Binder Hagit
General Manager
Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Pellizzari Christine A
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Binder Hagit
General Manager
Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Binder Hagit
General Manager
Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Binder Hagit
General Manager
Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Leuchtenberger Mark
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Leuchtenberger Mark
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Leuchtenberger Mark
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Golan Roy
Director
Director 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT NEUROSENSE THERAPEUTICS LTD.
NeuroSense Therapeutics
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE